SCHEMBL29545233

SCHEMBL29545233

CC(=O)n1ncc2cc(Cl)ncc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.54
AURKA O14965 1/20 0.54
DAPK3 O43293 1/20 0.54
CSNK1A1 P48729 1/20 0.54
GSK3A P49840 1/20 0.54
LIMK1 P53667 1/20 0.54
IKBKE Q14164 1/20 0.54
MAPK14 Q16539 1/20 0.54
TAOK1 Q7L7X3 1/20 0.54
CLK4 Q9HAZ1 1/20 0.54
DYRK1B Q9Y463 1/20 0.54
SLC22A12 Q96S37 2/20 0.39
CREBBP Q92793 1/20 0.38
CCR9 P51686 2/20 0.38
KMT2A Q03164 2/20 0.36
SHMT2 P34897 2/20 0.36
RAB9A P51151 2/20 0.36
MAPT P10636 2/20 0.36
NPC1 O15118 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL600231 1.00 CHEK1 (0.54) CHEK1AURKADAPK3CSNK1A1GSK3A
SCHEMBL17847964 0.85 CCR9 (0.39) CHEK1AURKADAPK3CSNK1A1GSK3A
SCHEMBL27856881 0.83 CCR9 (0.38) CHEK1AURKADAPK3CSNK1A1GSK3A
SCHEMBL7214066 0.81 CHEK1 (0.55) CHEK1AURKADAPK3CSNK1A1GSK3A
SCHEMBL4143895 0.80 CHEK1 (0.54) CHEK1AURKADAPK3CSNK1A1GSK3A
SCHEMBL17848025 0.79 ROCK2 (0.44) CHEK1AURKADAPK3CSNK1A1GSK3A
SCHEMBL17847998 0.79 MAPK1 (0.53) CHEK1AURKADAPK3CSNK1A1GSK3A
SCHEMBL19780078 0.78 CHEK1 (0.51) CHEK1AURKADAPK3CSNK1A1GSK3A
SCHEMBL7213866 0.76 CHEK1 (0.50) CHEK1AURKADAPK3CSNK1A1GSK3A
SCHEMBL16339834 0.74 CHEK1 (0.63) CHEK1AURKADAPK3CSNK1A1GSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114044800-A Aryl, heteroaryl and heterocyclic compounds for the treatment of medical disorders 艾其林医药公司 2022-02-15 CN disclosed